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EUROCARE-5—the latest iteration of the EUROCARE 
project to compare cancer survival across Europe—
covered the period during which the NHS Cancer 
Plan was implemented in England. The latest report1 
conﬁ rmed that survival of patients with some 
common epithelial cancers is poor in the UK and 
Ireland. The poor survival must be partly a result 
of presentation with ambiguous symptoms, which 
means that many patients need  three or more 
primary-care consultations before the diagnosis is 
reached, as shown by data from England for 2009–10,2 
when the principles of the NHS Cancer Plan were well 
established. 
Left untreated, most cancers progress from the 
initiating cell transformation event to a point when 
the tumour burden is inevitably fatal. The earlier a 
diagnosis can be made and treatment oﬀ ered, the 
better the potential outcome. Analysis of previous 
EUROCARE data3,4 showed that the poor survival in the 
UK and Ireland when compared with other European 
countries is most explained by a high number of 
deaths in the ﬁ rst year after diagnosis. Therefore, 
timing of diagnosis seems to be crucial. The reliance 
on primary-care gatekeeping to control access to 
diagnostic services in primary care in the UK and 
Ireland is probably highly important; other countries 
allow patients to have direct access to specialists. 
Denmark also has poorer survival than do Norway, 
Sweden, and Finland, which is associated with a similar 
reliance on primary care.1
Against this background, it is disconcerting that a 
strategy of several consultations and their associated 
delays has been proposed as a viable option to control 
and protect expensive secondary care resources from 
excessive demand.5 In The Lancet Oncology, Jonathan 
Banks and colleagues6 present results of a study in 
which they explored potential patients’ acceptance 
of diagnostic investigation in response to vignettes 
describing patterns of symptoms that carry a risk of 
a neoplasms of as little as 1% or 2%. 3052 (88%) of 
3469 participants opted for investigation in their ﬁ rst 
vignette. The vignettes and the ascribed risks of cancer 
were derived from careful observational studies in UK 
primary care and are a reﬂ ection of the reality of early 
symptomatic diagnosis of cancer.7 Investigation of a 
clinical presentation with a 2% risk of an underlying 
cancer needs 50 patients to be assessed for every 
patient for whom the diagnosis is made. Therefore, 
resources (ie, personnel and technology) necessary to 
undertake that investigation need to have adequate 
capacity and be readily accessible.  
A growing concern is that access to general 
practitioners in England and Wales could itself be 
restricted by gatekeeping. Publicity encourages 
people who have the sort of ambiguous symptoms 
that can indicate common cancers to seek the advice 
of a pharmacist whose bias must be towards sales 
of medicine. Additionally, individuals who do seek 
an appointment with a general practitioner are 
increasingly asked to have a telephone discussion with 
a member of the practice to ascertain if a personal 
consultation is justiﬁ ed.8
In the UK’s National Health Service, diagnosis 
and treatment have no direct costs to patients. 
Nevertheless, socioeconomic factors have a major 
bearing on who gets treatment for cancer and with 
what outcome. Banks and colleagues showed that 
higher household income was associated with an 
increased likelihood of opting for investigation for 
colorectal and pancreatic cancers.6 A family history of 
cancer was also associated with an increased likelihood 
of opting for investigation for colorectal and lung 
cancers. Another study9 suggested that patients who 
have a spouse have improved outcomes after cancer, 
which is probably mediated through pressure to 
seek advice. Distance from the investigating facility 
could be an inhibitory factor.6 Similar considerations 
most probably apply to the decision to make the ﬁ rst 
contact with a family doctor or to initiate a further 
contact after initial reassurance.  
An area that has not been researched is the 
approach of general practitioners. The so-called rule 
of optimism—ie, a preference not to believe that an 
undesirable situation might exist—might be being 
applied in some situations. The application of this 
rule has been explored in child protection: the urgent 
needs of the child being neglected or abused are not 
recognised by health and education agencies.10 The 
same pattern could exist in the diagnosis of new or 
indeed recurrent cancer; general practitioners would 
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prefer their patients not to have cancer and are 
therefore reluctant to give the possibility priority. If 
such thinking derives from a preference not to burden 
the patient with investigation for the small probability 
that a malignancy exists, the clear message from 
Banks and colleagues is that patients would prefer to 
have diagnostic testing. 
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